Patent ID: 7425570

Claim:
A method of inhibiting heparin induced thrombocytopenia in a mammalian patient comprising administering a therapeutically effective amount of a compound of Formula V: or a pharmaceutically acceptable acid addition salt thereof, wherein: R 5 is CH 2 OH or CHO; R 1 is n is an integer of 1 to 5; R 2 , R 3 , and R 4 are each independently hydrogen; alkyl; aryl or biaryl, wherein the aryl or biaryl can be substituted with a cyano, alkyl, alkoxy, amino, hydroxy, halo, nitro, or alkanoyloxy; amino; acylamino; anilino, wherein the aniline ring can be substituted with a cyano, alkyl, alkoxy, amino, hydroxy, halo, nitro, or alkanoyloxy; nitro; or guanidino.